Objective. Mycobacteria have been implicated in the pathogenesis of various forms of arthritis. The aim of this study was to examine the diagnostic potential of molecular biological techniques as well as to investigate the pathogenetic role of mycobacteria in chronic arthritis.
The arthritogenicity of mycobacteria is illustrated by [3] . The diagnosis of a mycobacterial infection can be their capacity to induce septic arthritis. Although hampered by the slow growth of mycobacteria or diffiMycobacterium tuberculosis is the most extensively docuculties in culturing. Although more rapid methods for mented example, several non-tuberculous mycobacteria the identification of cultured mycobacteria have been are also increasingly being recognized, including developed, alternatives to ensure a specific detection of Mycobacterium avium, Mycobacterium fortuitum, mycobacteria are provided by nucleic acid amplification Mycobacterium chelonae, Mycobacterium kansasii, techniques [3] . The principal advantages of polymerase Mycobacterium terrae and Mycobacterium marinum chain reaction (PCR)-based DNA amplification are that [1, 2] .
it can be applied directly on clinical specimens and The methods to identify mycobacterial species from provides a rapid diagnosis [3] . clinical samples usually require cultured mycobacteria As molecular microbiological techniques are evolving, they are also increasingly being utilized in studies addressing the aetiology and pathogenesis of various Submitted 27 October 1998 ; revised version accepted 29 January idiopathic chronic arthritides [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Infectious agents 1999. may be involved in the aetiology of chronic arthritis, Correspondence to: P. P. Tak, Department of Rheumatology, either as an inciting trigger or as a persistent antigenic Building 1, C4R, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands. drive in synovial inflammation. Recently, there has been renewed interest in the role of the intestinal bowel flora Specimen collection in the pathogenesis of seronegative spondyloarthropath-SF and/or ST samples were collected from knee joints ies (SpA), undifferentiated arthritis ( UA) and rheumausing the Parker-Pearson biopsy procedure with several toid arthritis (RA). The close relationship between the modifications [13] . Prior to the biopsy procedure, a skin gut and the joints is suggested by many clinical observabiopsy was removed which included the hair follicles to tions, e.g. reactive arthritis (ReA) after gastrointestinal avoid contamination of joint samples by skin flora. This infections and arthritis associated with chronic inflamwas followed by the sampling of SF and the application matory bowel disease [15] . Results from animal models of an intra-articular anaesthetic ( lidocaine 0.5%) via the showed an important role for normal enteric bacteria, site of the removed skin. The Parker-Pearson needle bacterial products and host genetic susceptibility in was also inserted via the skin biopsy site and 6-8 the pathogenesis of experimentally induced arthritis randomly taken ST biopsy samples were collected from [16] [17] [18] . Furthermore, several groups have shown evithe inflamed joint. From all joints other than the knee, dence of macroscopic and/or microscopic gut inflam-SF was obtained during routine aspiration. mation, which were unrelated to clinical intestinal All samples were stained, using a standard acid fast symptoms, in subsets of patients with SpA and UA [15] .
staining technique, and cultured for mycobacteria on A recent study also presented evidence for ultrastructural Lowenstein-Jensen medium, with or without pyruvate lesions along the gut wall in 50% of the patients with or glycerin [3] . In the positive mycobacterial culture, RA [19] . Damaged intestinal epithelium in these patients speciation was performed by a separate PCR using the could result in a defective defence against components insertion element IS6110, in a region coding for a M. of the microbial flora [20] . Consequently, dissemination tuberculosis-specific insertion, as the genetic target [3] . into the joint may take place, resulting in local All samples were also Gram stained and cultured using deposition of bacterial antigens and triggering of an standard techniques for common bacteria. inflammatory response, as has been argued, for example, After embedding formalin-fixed ST samples in parfor Yersinia enterocolitica-related arthritides [21] [22] [23] . As affin, sections were cut, and the tissue stained with mycobacterial species are members of the normal bowel haematoxylin and eosin for histological analysis. flora, it is conceivable that they might cause arthritis by DNA extraction similar mechanisms [24] .
The samples (500 ml SF and/or 6-8 biopsy specimens) The aim of this study was to detect the local presence were transferred into digestion buffer [500 m Tris of mycobacterial species in the inflammatory joints of (pH 9), 20 m EDTA, 10 m NaCl, 1% SDS, 0.5 mg/ml patients with mycobacterial septic arthritis, SpA, UA or proteinase K ] and incubated for 18 h at 60°C to release RA. For this purpose, a mycobacterial genus-specific total DNA. The digested material was extracted with PCR, based on the 16S rRNA gene, was applied on Tris-EDTA-buffered phenol (pH 7.4), ethanol precipit-DNA extracts isolated directly from synovial fluid (SF ) ated and the DNA pellet was resuspended in 25-100 ml and/or synovial tissue (ST ) samples derived from of sterile water, depending on the viscosity of the inflamed joints. The sequences of the amplified myco-DNA extract. bacterial DNA were subsequently analysed. Patients with non-mycobacterial septic arthritis, osteoarthritis
Mycobacterial PCR (OA), gout or joint trauma served as negative controls.
For the PCR, primers based on the mycobacterial 16S rRNA gene were used which correspond to residues 8-27 and 590-571 of the Escherichia coli 16S rRNA
Patients and methods sequence: 5∞-AGAGTTTGATCCTGGYTCAG-3∞ and 5∞-TTTCACGAACAACGCGACAA-3∞, respectively. Patients DNA amplification was carried out in 25 ml reaction One hundred patients with an arthritis of at least one volumes. Each reaction contained 5 pmol of each primer, joint were included in the study. These 100 patients 0.25 U of SuperTth polymerase (HT Biotechnology, fulfilled the criteria for either septic arthritis, acid fast Cambridge, UK ), 55 ng TaqStart (Clontech, Palo Alto, positive or culture proven (n = 5); SpA, including ankyl-USA), 200 m of each dNTP, 50 m Tris-HCl (pH 9), osing spondylitis (n = 2), ReA (n = 7), enteropathic 1.5 m MgCl 2 , 50 m KCl, 0.1% Triton X-100 and arthritis (n = 2) and psoriatic arthritis (n = 7) [25] ; UA, 0.01% gelatin. A 35 ml overlay of sterile mineral oil was based on the exclusion of other rheumatic diseases added, followed by 5 ml DNA extract. A touch-down (n = 21); RA (n = 40) [26 ] ; OA (n = 7) [27] ; crystal PCR was used [29]: 3 min at 95°C followed by two arthropathy (n = 8) [28]; or post-traumatic joint effucycles of 20 s at 95°C, 1 min at 66°C and 1 min at 72°C; sion (n = 1). The disease duration, as measured from then two cycles identical to the previous two cycles, but the first clinical signs of arthritis, was documented. The with an annealing temperature of 64°C. The annealing patients gave informed consent and were followed for temperature was subsequently decreased by 2°C every at least 1 yr to allow confirmation of the accuracy of two cycles, until an annealing temperature of 56°C was the diagnosis. The study protocol was approved by the reached. At this temperature, 40 additional cycles were medical ethics committee of Leiden University Medical run and the programme ended with 7 min at 72°C. All PCRs were carried out in an OmniGene Thermal Cycler Centre.
(Hybaid Ltd, Teddington, Middlesex, UK ). Primers containing a PCR band was performed. This gel slice was extracted and reamplified to monitor contamination were synthesized by Perkin-Elmer Cetus (Gouda, The Netherlands).
due to environmental mycobacteria present during electrophoresis.
PCR product detection
Sample processing and analysis were performed by investigators who were unaware of the clinical features The PCR amplicons were checked by electrophoresis of 20 ml of the reaction mixture in an ethidium bromideof the patients. stained 1.5% agarose gel. A 1 kilobase (kb) DNA ladder (Gibco BRL, Life Technologies B.V., Breda, The Netherlands) was used as a DNA size standard. The Results DNA was visualized on a UV transilluminator and Patients photographed. Positive bands were excised and eluted O/N in 100 ml H 2 O. Depending on the presence of The clinical features and demographic characteristics of the various patient groups are shown in Table 1 . One inhibitory factors in individual clinical samples, the detection limit of the PCR was 1-5 copies of the 16S of the two patients with mycobacterial septic arthritis visited the out-patient clinic for analysis of pain and gene, corresponding to 20-100 copies/ml SF (data not shown). Re-amplification of the eluted amplicons after swelling of the right knee joint which had persisted for 2 yr. Direct acid-fast staining of the SF collected from 1:1000 dilution was performed (25 cycles at 56°C under the same conditions) with the same primers and the knee was negative, but mycobacterial culture, using Lowenstein-Jensen agar, was positive. The mycoamplicons were purified using a Qiagen PCR purification kit (Diagen, Hilden, Germany).
bacterial PCR, here using the IS6110 as genetic target, performed on the cultured isolate, revealed the presence Sequence analysis of M. tuberculosis complex. Histopathological examination of the sampled ST showed a white central caseating The PCR amplicons were sequenced using fluorescentlabelled dideoxynucleotides in the Applied Biosystems granuloma. Separate biopsy specimens were used for PCR analysis directly on the clinical samples. The second cycle sequencing system (Applied Biosystems/Perkin Elmer). Searches for sequence similarity were carried patient with mycobacterial septic arthritis visited the out-patient clinic because of persisting swelling of the out using the FastA program on EMBL data banks [30] .
right hand and wrist. He mentioned that he owned a Prevention of contamination and controls tropical fish tank. This patient had been treated with several courses of oral antibiotics, namely floxapen and During the collection of SF and biopsy specimens, and during the transfer of SF and ST into digestion buffer augmentin. Tissue examination of an early biopsy specimen revealed granulomatous inflammation and long in a biosafety hood, control vials with digestion buffer were simultaneously opened and closed with sample acid-fast particles. Culture of the affected tissue was negative. Treatment with doxycycline, and later ciproxin, collection vials (collection controls). DNA extraction and the preparation of the PCR mixtures were perwas prescribed in view of a possible M. marinum infection. As the tenosynovitis persisted, a radical excision formed in separate, specially dedicated positive-pressure laboratories (>10 Pa) with a lock-gate in a biosafety of the inflamed tissue was performed, and samples were used for PCR analysis in this study. Histopathological hood, equipped with UV germicidal lamps. Dedicated pipettes with disposable filtertips, disposable gloves and examination of the specimen revealed a granulomatous lesion with fibrinoid necrosis. Mycobacterial stain and labcoats, and non-reusable waste containers were used in both rooms. PCR spiking and product detection, culture of the tissue were now negative. Staphylococcus aureus (n = 1), Neisseria gonorrhoeae and sequence analysis, were performed in a different laboratory.
(n = 1) and Streptococcus pyogenes (n = 1) were cultured from the SF of a knee and elbow joint, respectively, Negative controls, to check for cross-contamination of samples, were included after every second clinical from two patients, and from the SF and ST of a knee joint from a third patient with septic arthritis. Bacterial sample (extraction controls). These negative controls consisted of digestion buffer without clinical material, agents involved in the cases of ReA determined using serological assays for Yersinia, Chlamydia and streptoand were handled in the same way as the clinical samples. Positive as well as negative controls were cocci, and culture of the faeces and urethra, were Salmonella typhimurium (n = 2), Campylobacter jejuni included in each experiment. Positive controls consisted of reaction mixtures, spiked with 0.2 pg of chromosomal (n = 1), Chlamydia trachomatis (n = 1) and Streptococcus group A (n = 2). In one patient with Reiter's syn-DNA of Mycobacterium paratuberculosis in H 2 O. In addition, each clinical DNA extract was also spiked to drome, the bacterial agent could not be determined. Except for the samples from the two patients with detect the presence of PCR inhibiting factors. To test the PCR reaction mixture itself for contamination of mycobacterial septic arthritis, none of the SF and/or ST samples from the other patients were either acid-fast components, a negative control consisting of reaction mixture without DNA template was also included in positive or mycobacterial culture positive. Pathology reports of ST examination did not reveal any granuloeach experiment (reaction mix control ).
As gel extraction control, excision of a gel slice not matous lesions. The data represent the median (range). aOther arthritides: osteoarthritis (n = 7); crystal arthropathies (n = 8); joint trauma (n = 1); non-mycobacterial septic arthritis (n = 3). PCR analysis samples from a patient with a crystal arthropathy. No specific clinical features were observed in the patients in In the positive control group, a DNA product of whom mycobacterial DNA was detected. 582 bp was amplified using a mycobacterial genusIn the collection, extraction and reaction mix controls, specific PCR from DNA extracts of both SF and ST no mycobacterial DNA product was present, indicating samples from the first patient. On sequencing this DNA the effect of the stringent measures to prevent crossproduct, 100% identity was found with both M. tubercucontamination. During PCR analysis of the clinical losis complex and Mycobacterium bovis (this fragment samples, no amplicons of the spike DNA (M. paratuberof the 16S gene contains no difference between these culosis) were found, showing that no laboratory crosstwo species). Analysing the inflamed tissue samples from contamination had occurred. the second patient also showed a positive PCR result. Sequence analysis revealed 100% homology to that of M. marinum. Synovial fluid was not available from Discussion this patient.
Mycobacterial DNA was detected in SF and/or ST In this study, mycobacterial DNA was amplified from SF and ST samples of two patients with mycobacterial from three of the 40 patients with RA, but in none of the samples from the 18 patients with SpA or the 21 septic arthritis. This was accomplished using a genusspecific PCR for mycobacteria on DNA extracts isolated patients with UA. Furthermore, mycobacterial DNA was detected in the SF, but not ST, from one of seven directly from the joint samples, followed by sequence analysis of the PCR products. Using the same approach, OA patients and in the ST, but not SF, from one out of the eight patients with crystal arthropathy. After mycobacterial DNA was identified in the joint samples of three patients with RA, one patient with a crystalsequencing and comparative data analysis of the mycobacterial 16S gene amplicons from the SF and/or ST induced arthropathy and one patient with OA. A similar PCR assay based on DNA coding for 16S samples, the following percentages of sequence similarity with known mycobacterial species were found: M. hodrRNA for the detection and identification of mycobacteria in clinical samples has been described previously leri (97%) in one patient with RA; M. smegmatis was detected in the joint samples from one patient with OA, [31, 32] . The 16S rRNA gene is a suitable target for amplifying mycobacterial nucleic acids at the genus and two other patients with RA: 94% and twice 98%, respectively; and M. austroafricanum (98%) in the joint level, and differentiating at the species level with a set of species-specific probes or by sequence analysis [33, samples could mean one of the following. Firstly, it is possible that the detection of the mycobacterial species 34]. The possible applications of a specific mycobacterial PCR in rheumatological practice have been proposed reflects the presence of irrelevant bacterial DNA in, for example, phagocytes entering the inflammatory joints. previously [32, 35] . One case report describes species diagnosis using the analysis of the mycobacterial 16S
This would accord with the data from a previous study, applying a universal PCR with broad-range 16S rRNA rRNA gene on a cultured isolate derived from excised s.c. nodules [32] . In another case report, M. avium gene primers, in which we demonstrated that DNA products from several bacterial species can be present complex was identified in DNA extracts isolated directly from both skin and ST [35] . Three weeks later, culture in the inflamed joints of patients with ReA and UA [13] . Secondly, the detection of the mycobacterial confirmed the presence of M. avium. The potential of molecular microbiological methods as a diagnostic tool sequences could be explained by the occurrence of contamination. However, this is highly unlikely because in culture-negative tuberculous tenosynovitis and arthritis was also demonstrated in a patient who had just of the extensive precautions taken during tissue sampling and analysis, and the absence of any mycobacterial been treated for pulmonary tuberculosis [36 ] .
The results from the present study further support DNA in the negative collection and laboratory controls. Although this study does not substantiate a significant the potential of this molecular microbiological tool in the diagnosis of mycobacterial septic arthritides.
local role for mycobacteria in the pathogenesis of SpA, UA and RA, its place in the pathogenesis of these However, further investigation of larger numbers of patients is clearly warranted. The detection of nucleic arthritic processes should not yet be completely dismissed. It is still possible that a mycobacterial infection acid sequences from mycobacteria in the joint samples from five of the 98 patients in the study group with occurs outside the joints, inducing a cross-reactive immune reaction affecting the joints. Studies on the other arthritides, for example, indicates the importance of only applying this technique when a high degree of cellular and humoral immune responses in these diseases will have to clarify this issue. Alternatively, a mycosuspicion of a mycobacterial infection exists. The discordant results between the culture and the mycobacterial infection in the synovium, or at an alternative site in the body, might be present at a very early stage bacterial genus-specific 16S rRNA-based PCR results (negative culture, positive PCR) in the second patient and could disappear after triggering the immune system. Furthermore, perhaps not whole bacteria or bacterial with mycobacterial arthritis may be explained by a nonuniform distribution of microorganisms under paucibacnucleic acids, but only mycobacterial cell wall fragments that are transported from, for example, the bowel, are illary conditions, or by the use of antimicrobial treatment prior to the radical excision of the diseased tissue.
deposited locally in the joint, resulting in inflammation. Such a mechanism has also been postulated for the The detection of mycobacteria in the joint samples of only three of the 40 patients with RA, and in none of pathogenesis of Yersinia-induced ReA [21] [22] [23] . Antigen detection, performed on SF and ST samples, may conthe patients with SpA and UA, does not favour a pathogenetic role for mycobacteria, or mycobacterial firm or contest this hypothesis.
In conclusion, this study supports the further explora-DNA, in the inflamed joints of patients with chronic arthritis. Previous work has also failed to provide such tion of the diagnostic potential of a genus-specific PCR for mycobacteria on DNA extracts isolated directly evidence [4, 5] . We cannot, however, exclude the possibility that mycobacteria are involved in the pathogenfrom joint samples with subsequent sequence analysis. The results do not provide evidence for a local role of esis of arthritis in the subset of three RA patients. Nevertheless, the detection of mycobacterial DNA in mycobacteria in the joints of patients with RA, SpA or UA. the joint samples from two patients with OA and crystal arthropathy, respectively, warrants a note of caution in the interpretation of these findings.
